help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on September 28, 2006, doi:10.1164/rccm.200605-676OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200605-676OCv1
174/12/1370    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lakshminrusimha, S.
Right arrow Articles by Steinhorn, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lakshminrusimha, S.
Right arrow Articles by Steinhorn, R. H.
American Journal of Respiratory and Critical Care Medicine Vol 174. pp. 1370-1377, (2006)
© 2006 American Thoracic Society
doi: 10.1164/rccm.200605-676OC


Original Article

Superoxide Dismutase Improves Oxygenation and Reduces Oxidation in Neonatal Pulmonary Hypertension

Satyan Lakshminrusimha, James A. Russell, Stephen Wedgwood, Sylvia F. Gugino, Jeffrey A. Kazzaz, Jonathan M. Davis and Robin H. Steinhorn

Departments of Pediatrics and Physiology and Biophysics, State University of New York at Buffalo, Buffalo; Departments of Pediatrics and Medicine, and the CardioPulmonary Research Institute, Winthrop-University Hospital, State University of New York at Stony Brook, Mineola, New York; and Department of Pediatrics, Northwestern University, Chicago, Illinois

Correspondence and requests for reprints should be addressed to Satyan Lakshminrusimha, M.D., Division of Neonatology, Women and Children's Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222. E-mail: slakshmi{at}buffalo.edu

Rationale: Hyperoxic ventilation in the management of persistent pulmonary hypertension of the newborn (PPHN) can result in the formation of reactive oxygen species, such as superoxide anions, which can inactivate nitric oxide (NO) and cause vasoconstriction and oxidation.

Objective: To compare the effect of intratracheal recombinant human superoxide dismutase (rhSOD) and/or inhaled NO (iNO) on systemic oxygenation, contractility of pulmonary arteries (PAs), and lung reactive oxygen species (isoprostane, 3-nitrotyrosine) levels in neonatal lambs with PPHN.

Methods: Six newborn lambs with PPHN (induced by antenatal ductal ligation) were killed at birth. Twenty-six PPHN lambs were ventilated for 24 h with 100% O2 alone (n = 6) or O2 combined with rhSOD (5 mg/kg intratracheally) at birth (n = 4), rhSOD at 4 h of age (n = 5), iNO (20 ppm, n = 5), or rhSOD + iNO (n = 6). Contraction responses of fifth-generation PAs to norepinephrine and KCl, lung isoprostane levels, and 3-nitrotyrosine fluorescent intensity were measured.

Results: Systemic oxygenation was impaired in PPHN lambs and significantly improved (up to threefold) in both rhSOD groups with or without iNO. Oxygenation improved more rapidly with the combination of rhSOD + iNO compared with either intervention alone. Norepinephrine- and KCl-induced contractions and lung isoprostane levels were significantly increased by 100% O2 compared with nonventilated newborn lambs with PPHN. Both rhSOD and iNO mitigated the increased PA contraction response and lung isoprostane levels. Intratracheal rhSOD decreased the enhanced lung 3-nitrotyrosine fluorescence observed with iNO therapy.

Conclusion: Intratracheal rhSOD and/or iNO rapidly increase oxygenation and reduce both vasoconstriction and oxidation in newborn lambs with PPHN. This has important implications for clinical trials of rhSOD and iNO in newborn infants with PPHN.

Key Words: isoprostanes • nitric oxide • oxygen • pulmonary hypertension • superoxide dismutase


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Hyperoxic ventilation causes oxidant injury and can contribute to worsening of pulmonary hypertension in newborns.

What This Study Adds to the Field
Intratracheal recombinant human superoxide dismutase improves oxygenation and reduces pulmonary arterial contractility and oxidation (isoprostane levels) in an ovine model of neonatal pulmonary hypertension

 



This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. P. Jankov, C. Kantores, J. Pan, and J. Belik
Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L233 - L245.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Kamezaki, H. Tasaki, K. Yamashita, M. Tsutsui, S. Koide, S. Nakata, A. Tanimoto, M. Okazaki, Y. Sasaguri, T. Adachi, et al.
Gene Transfer of Extracellular Superoxide Dismutase Ameliorates Pulmonary Hypertension in Rats
Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 219 - 226.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Lakshminrusimha, D. Wiseman, S. M. Black, J. A. Russell, S. F. Gugino, P. Oishi, R. H. Steinhorn, and J. R. Fineman
The role of nitric oxide synthase-derived reactive oxygen species in the altered relaxation of pulmonary arteries from lambs with increased pulmonary blood flow
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1491 - H1497.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society